WIGGINS MARK C 4
4 · Tracon Pharmaceuticals, Inc. · Filed Sep 14, 2020
Insider Transaction Report
Form 4
WIGGINS MARK C
Chief Business Officer
Transactions
- Purchase
Common Stock
2020-09-10$4.14/sh+7,000$28,953→ 12,350 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.125 to $4.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F2]Includes 350 shares acquired by the reporting person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2020.